Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

Rapid PCR-RFLP Screening of CYP21A2 Variants: Bridging Molecular Diagnostics in a Low-Resource Setting

Journal of Biomedicine and Translational Research · Vol. 12 No. 1 (2026) · hlm. 28–35

DOI
10.14710/jbtr.v12i1.30107
ISSN
2503-2178
Terbit
2026-04-30
Penerbit
Faculty of Medicine, Universitas Diponegoro
Bahasa
eng
Lisensi
creativecommons.org/licenses/by-sa/4.0

Abstrak

Background: The 21-hydroxylase deficiency (21OHD) accounted for the majority of autosomal recessive inherited congenital adrenal hyperplasia (CAH) cases. A genetic test could offer a more thorough diagnostic approach because of the wide range of disease’s severity, but it was challenging in a resource-limited setting.Objective: To apply a simple and cost-effective rapid molecular screening for detecting the most common CYP21A2 variants causing salt-wasting (SW) CAH.Methods: DNA extraction was conducted using a salting out method from a venous blood sample taken from 49 CAH patients without prior genetic testing. A PCR-RFLP approach was utilized using primer sets specifically designed to anneal to the CYP21A2. Specific restriction enzymes were selected to cleave the DNA sequence, differentiating the wild and mutant type, i.e, the p.Arg357Trp, p.Gln318Ter, IVS2-13A/C>G, and exon 6 cluster. Samples positive for those mutation types detected from DNA sequencing, used as positive controls.Results: The most common variant was IVS2-13A/C>G, detected in 26 out of 27 patients. Only 6.1% of 49 patients were found to have the p.Gln318Ter variant. Both the p.Arg357Trp and exon 6 cluster carried inconclusive results. All patients detected with the IVS2-13A/C>G and p.Gln318Ter had a phenotype of SW CAH.Conclusion: The PCR-RFLP was an advantageous method for identifying CYP21A2 variants in a low-resource setting. Nevertheless, the use of multiplex ligation-probe dependent amplification (MLPA) and Sanger sequencing offered a comprehensive analysis to discover novel variants that could help with patients' diagnosis and treatment.

Kata kunci

Jaringan kolaborasi para penulis

40 penulis · 125 tautan kepenulisan bersama · 13 lintas organisasi · menampilkan 40 yang paling banyak terhubung

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Diponegoro University
  • State University of Semarang
  • National Research and Innovation Agency
  • Padjadjaran University
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Sultana MH FaradzDiponegoro University13
Udin BahrudinDiponegoro University3
Maria MexitaliaDiponegoro University3
Etika Ratna NoerDiponegoro University2
Faizah FulyaniDiponegoro University2
Annastasia EdiatiDiponegoro University2
Magdalena SidhartaniDiponegoro University2
J. JamariDiponegoro University2
Mohamad Izzur MaulaDiponegoro University2
M. Danny Pratama LamuraDiponegoro University2
Hasyid Ahmad WicaksonoDiponegoro University2
Ferdy Kurniawan CayamiDiponegoro University2
Nydia Rena Benita SihombingDiponegoro University2
Herera RahajengDiponegoro University1
Awal PrasetyoDiponegoro University1
Neni SusilaningsihDiponegoro University1
Udadi SadhanaDiponegoro University1
Hairul AsriDiponegoro University1
Qonita Nur QolbyState University of Semarang1
Muflihatul MunirohDiponegoro University1
Julian DewantiningrumDiponegoro University1
Besari Adi PramonoDiponegoro University1
Eka Djatnika NugrahaNational Research and Innovation Agency1
Elsa GusriantiDiponegoro University1
Ani Melani MaskoenPadjadjaran University1
Bremmy LaksonoDiponegoro University1
Syarief TaufikDiponegoro University1
Hery Djagat PurnomoDiponegoro University1
Rayvita AN MeagratiaDiponegoro University1
Wiwik LestariDiponegoro University1
Adriyan PramonoDiponegoro University1
Kezia Yunandra KurniawanDiponegoro University1
Monica Hermina Sharon Otline YockuDiponegoro University1
Rachmania Anggita SavitriDiponegoro University1
Arynal HaqDiponegoro University1
Muhammad Thifan SatyagrahaDiponegoro University1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) https://ejournal2.undip.ac.id/index.php/jbtr/oai, pertama di-harvest 9 Nov 2026, terakhir terlihat 9 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Rapid PCR-RFLP Screening of CYP21A2 Variants: Bridging Molecular Diagnostics in a Low-Resource Setting</dc:title>
	<dc:creator>Larasati, Irene Astrid</dc:creator>
	<dc:creator>Maharani, Nani</dc:creator>
	<dc:creator>Utari, Agustini</dc:creator>
	<dc:creator>Winarni, Tri Indah</dc:creator>
	<dc:subject xml:lang="en-US">Congenital adrenal hyperplasia; CYP21A2; PCR; RFLP; developing country</dc:subject>
	<dc:description xml:lang="en-US">Background: The 21-hydroxylase deficiency (21OHD) accounted for the majority of autosomal recessive inherited congenital adrenal hyperplasia (CAH) cases. A genetic test could offer a more thorough diagnostic approach because of the wide range of disease’s severity, but it was challenging in a resource-limited setting.Objective: To apply a simple and cost-effective rapid molecular screening for detecting the most common CYP21A2 variants causing salt-wasting (SW) CAH.Methods: DNA extraction was conducted using a salting out method from a venous blood sample taken from 49 CAH patients without prior genetic testing. A PCR-RFLP approach was utilized using primer sets specifically designed to anneal to the CYP21A2. Specific restriction enzymes were selected to cleave the DNA sequence, differentiating the wild and mutant type, i.e, the p.Arg357Trp, p.Gln318Ter, IVS2-13A/C&gt;G, and exon 6 cluster. Samples positive for those mutation types detected from DNA sequencing, used as positive controls.Results: The most common variant was IVS2-13A/C&gt;G, detected in 26 out of 27 patients. Only 6.1% of 49 patients were found to have the p.Gln318Ter variant. Both the p.Arg357Trp and exon 6 cluster carried inconclusive results. All patients detected with the IVS2-13A/C&gt;G and p.Gln318Ter had a phenotype of SW CAH.Conclusion: The PCR-RFLP was an advantageous method for identifying CYP21A2 variants in a low-resource setting. Nevertheless, the use of multiplex ligation-probe dependent amplification (MLPA) and Sanger sequencing offered a comprehensive analysis to discover novel variants that could help with patients' diagnosis and treatment.</dc:description>
	<dc:publisher xml:lang="en-US">Faculty of Medicine, Universitas Diponegoro</dc:publisher>
	<dc:date>2026-04-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US"></dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/30107</dc:identifier>
	<dc:identifier>10.14710/jbtr.v12i1.30107</dc:identifier>
	<dc:source xml:lang="en-US">Journal of Biomedicine and Translational Research; Vol 12, No 1 (2026): April 2026; 28-35</dc:source>
	<dc:source>2503-2178</dc:source>
	<dc:source>10.14710/jbtr.v12i1</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/view/30107/14196</dc:relation>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/30107/7440</dc:relation>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/30107/7441</dc:relation>
	<dc:relation>https://ejournal2.undip.ac.id/index.php/jbtr/article/downloadSuppFile/30107/8084</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2026 Journal of Biomedicine and Translational Research</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-sa/4.0</dc:rights>
</oai_dc:dc>